Format

Send to

Choose Destination
Mol Med Today. 2000 Sep;6(9):347-57.

PI3-kinase inhibition: a target for drug development?

Author information

1
The Ludwig Institute for Cancer Research and Department of Oncology, Royal Free and University College London Medical School, 91 Riding House Street, London, UK W1W 7BS. rstein@ludwig.ucl.ac.uk

Abstract

The phosphoinositide 3-kinases (PI3-kinases) are a ubiquitously expressed enzyme family that, through the generation of phospholipid second messengers, play a key role in the regulation of many cellular processes. These include motility, proliferation and survival, and carbohydrate metabolism. Members of the PI3-kinase family and related kinases, their mechanism of activation and the cellular events that they influence are described in this review. As knowledge of their involvement in disease processes increases, the PI3-kinases appear to be an increasingly attractive target for drug development, particularly in the fields of cancer and other proliferative diseases, and in the treatment of inflammatory and immunological conditions. Evidence of the functional specialization of PI3-kinase isoforms suggests that selective inhibition with acceptable toxicity might be possible.

PMID:
10954868
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center